It is possible that BP arises as a result of overactive T cells, uninhibited by immunotherapy, targeting BP180 on tumour cells and basement membrane.1–4 According to some studies, these adverse cutaneous reactions have a positive value, because they are associated with a higher rate of treatment success and longer progression-free disease survival. Here, COL17A1 is linked to neoplasm.